When should a transesophageal echocardiogram (TEE) be performed in patients with atrial fibrillation?

When to Perform TEE in Atrial Fibrillation

TEE should be performed in AF patients when you want to proceed with cardioversion but cannot wait 3 weeks for therapeutic anticoagulation, or when AF duration exceeds 48 hours (or is unknown) and early cardioversion is desired. 1, 2, 3

Primary Indication: TEE-Guided Early Cardioversion

The TEE-guided approach is an alternative to 3 weeks of therapeutic anticoagulation before cardioversion in patients with AF >48 hours or unknown duration. This strategy allows you to:

• Exclude left atrial/left atrial appendage thrombus
• Proceed immediately to cardioversion if no thrombus is found
• Avoid the 3-week waiting period while maintaining stroke prevention

The landmark ACUTE trial demonstrated this approach is equally safe for preventing embolic events (0.8% vs 0.5%, p=0.50) compared to conventional 3-week anticoagulation, with significantly fewer hemorrhagic complications (2.9% vs 5.5%, p=0.03), shorter time to cardioversion (3.0 vs 30.6 days), and higher success rates (71.1% vs 65.2%) 2, 4.

Specific Clinical Scenarios for TEE

Perform TEE when:

1. AF duration >48 hours or unknown AND you want cardioversion sooner than 3 weeks 1, 3

   • Start therapeutic anticoagulation immediately
   • Perform TEE on full anticoagulation (heparin or therapeutic oral anticoagulants)
   • If no thrombus: proceed to cardioversion immediately
   • Continue anticoagulation for ≥4 weeks post-cardioversion

2. Thrombus detected on initial TEE 1

   • Postpone cardioversion
   • Continue anticoagulation for 4-12 weeks
   • Consider repeat TEE (individualized decision)
   • Reassess for thrombus resolution or endothelialization

3. Patient cannot tolerate 3-week anticoagulation delay due to:

   • Severe symptoms despite rate control
   • Clinical urgency (though not hemodynamic instability)
   • Patient preference for expedited treatment 5

TEE is NOT routinely needed when:

1. AF duration <48 hours (especially <12 hours) 6, 5

   • Start anticoagulation at presentation
   • Proceed directly to cardioversion
   • Exception: Consider TEE if CHADS₂ ≥2 and duration 12-48 hours (weak recommendation)

2. Hemodynamic instability 1

   • Cardioverse immediately without delay
   • Start anticoagulation concurrently if possible
   • Continue for ≥4 weeks post-cardioversion

3. Patient already on therapeutic anticoagulation for ≥3 weeks 1

   • Proceed directly to cardioversion
   • TEE adds minimal value in this scenario

Critical Technical Points

Timing matters: Perform TEE while patient is on therapeutic anticoagulation (heparin or therapeutic oral anticoagulants), then cardiovert immediately afterward while still anticoagulated. Do NOT perform TEE off anticoagulation, as thrombus can form between TEE and achieving therapeutic anticoagulation 7.

Post-TEE management: Even with negative TEE (no thrombus), therapeutic anticoagulation must continue during and for ≥4 weeks after cardioversion due to atrial stunning, which can cause new thrombus formation despite restoration of sinus rhythm 2, 7, 3.

Common Pitfalls to Avoid

• Don't assume negative TEE eliminates stroke risk: 17 patients in one series had embolic events 2 hours to 7 days post-cardioversion despite negative TEE—none were on therapeutic anticoagulation at time of embolism 7

• Don't skip anticoagulation after negative TEE: Atrial mechanical dysfunction ("stunning") persists post-cardioversion and increases thrombosis risk regardless of pre-cardioversion TEE findings 2

• Don't use TEE to decide on long-term anticoagulation: Base this decision on stroke risk scores (CHA₂DS₂-VASc), not cardioversion success or TEE findings 1, 5

Special Populations

Patients on NOACs: TEE-guided cardioversion works equally well with NOACs as with warfarin. The convenience of immediate therapeutic effect makes NOACs particularly suitable for pericardioversion period 5.

Post-thoracic surgery with esophageal procedures: If TEE contraindicated (esophagectomy, esophageal pathology), use rate control strategy with 3 weeks therapeutic anticoagulation before cardioversion. Cardiac CT may have utility but lacks outcomes data 7.

Detection rates: TEE identifies left atrial thrombus in approximately 3-10% of AF patients and spontaneous echo contrast in 38-57% even in anticoagulated patients 8, 9. These findings mandate postponing cardioversion.